Sichuan Huiyu Pharmaceutical Co., Ltd. (SHA:688553)

China · Delayed Price · Currency is CNY

11.13

-0.22 (-1.94%)

Sep 10, 2026, 1:14 PM CST

SHA:688553 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,097	998.14	1,094	927.08	1,493	1,824
Revenue Growth	8.04%	-8.79%	18.05%	-37.92%	-18.12%	33.68%
Gross Profit	848.47	789.14	906.8	794.32	1,313	1,664
Operating Income	60.54	18.73	60.98	6.39	136.66	433.49
Net Income	113.41	-24.96	325.39	139.79	248.99	445.86
Earnings Per Share	0.18	-0.04	0.52	0.22	0.40	0.81
EPS Growth	-37.22%	-	133.32%	-44.05%	-50.84%	26.31%

Revenue by Geography

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
China	782.05
Overseas	216.09
Total	998.14

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	2,779	2,682	3,017	2,572	2,582	2,968
Total Debt	730.19	624.34	590.72	431.63	55.09	20
Net Cash (Debt)	2,049	2,058	2,426	2,140	2,527	2,948
Net Cash Growth	-1.66%	-15.19%	13.38%	-15.31%	-14.29%	391.73%
Net Cash Per Share	3.29	3.34	3.88	3.41	4.04	5.36

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	209.1	90.51	242.96	66.93	194.06	446.36
Capital Expenditures	-76.87	-105.27	-128.18	-296.72	-461.61	-433.45
Free Cash Flow	132.23	-14.76	114.78	-229.79	-267.55	12.91
Free Cash Flow Growth	65.96%	-	-	-	-	-94.36%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	77.35%	79.06%	82.86%	85.68%	87.94%	91.22%
Operating Margin	5.52%	1.88%	5.57%	0.69%	9.15%	23.77%
Pretax Margin	8.21%	-6.44%	31.95%	14.25%	15.96%	26.19%
Profit Margin	10.34%	-2.50%	29.73%	15.08%	16.67%	24.45%
FCF Margin	12.05%	-1.48%	10.49%	-24.79%	-17.92%	0.71%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	0.135	0.135	0.313	0.144	0.159	0.143
Dividend Per Share Growth	-36.10%	-56.84%	117.51%	-9.38%	11.36%	-
Dividend Yield	1.16%	1.14%	3.17%	1.49%	1.62%	0.68%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	62.28	-	19.79	45.85	26.52	31.95
P/FCF Ratio	53.54	-	56.10	-	-	1103.46
PS Ratio	6.45	7.51	5.88	6.91	4.42	7.81